Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03702231
Brief Title: Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

First Submitted : October 10, 2018
First Submitted that Met QC Criteria : October 10, 2018
First Posted : October 11, 2018

Certification/Extension First Submitted : April 12, 2021
Certification/Extension First Submitted that Met QC Criteria : April 21, 2021
Certification/Extension First Posted : April 23, 2021

Last Update Submitted that Met QC Criteria : April 21, 2021
Last Update Posted : April 23, 2021